MHRA updates guidance for resuming on-site inspections amid coronavirus (COVID-19)

MHRA updates guidance for resuming on-site inspections amid coronavirus (COVID-19)

The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its guidance for industry on MHRA’s expectations for a return to UK on-site inspections. The update includes information on how on-site inspections will resume at the end of March 2021. The guidance also confirmed that the MHRA Inspectorate will continue to use remote and on-site inspection approaches, while following the government's coronavirus (COVID-19) guidelines.

Sources:

• Guidance for industry on MHRA’s expectations for return to UK on-site inspections

• MHRA: In-person inspections to start 29 March

Related Articles:
Latest Articles: